| Dr Michael Kimmel, PHARMD | |
|
10 Industrial Ave, Chelmsford, MA 01824-3610 | |
| (978) 250-1018 | |
| Not Available |
| Full Name | Dr Michael Kimmel |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 10 Industrial Ave, Chelmsford, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013443209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH236331 (Massachusetts) | Primary |
| 183500000X | Pharmacist | PCT.0013558 (Connecticut) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Kimmel, PHARMD 16 Cannongate Rd Apt 5, Tyngsboro, MA 01879-1415 Ph: () - | Dr Michael Kimmel, PHARMD 10 Industrial Ave, Chelmsford, MA 01824-3610 Ph: (978) 250-1018 |
News Archive
Nearly two-thirds of the hospital in-patients who took part in a survey had experienced pain in the last 24 hours and 42% of those rated their pain as more than seven out of ten, where ten was the worst pain imaginable, according to the March issue of the Journal of Clinical Nursing.
Reflecting physicians' frustration with a group of senators that blocked action last week on legislation that would stop harsh Medicare physician payment cuts, the AMA began airing new TV and radio ads urging opponents of H.R. 6331 to put patients' access to care before insurance profits.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
› Verified 3 days ago
Joane Elizabeth Golden, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Industrial Ave, Chelmsford, MA 01824 Phone: 978-244-1300 | |
Mr. Paul Richard Shandrowski, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Industrial Avenue, Chelmsford, MA 01824 Phone: 978-244-1300 | |
Mr. Chris J Conisha, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Industrial Ave, Chelmsford, MA 01824 Phone: 978-244-1306 Fax: 978-244-1315 | |
Aarti Mehta, DOCTOR OF PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 66 Parkhurst Rd, Chelmsford, MA 01824 Phone: 978-459-6366 | |
Mrs. Patrice Anntoinette Palmer-russell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Industrial Ave, Chelmsford, MA 01824 Phone: 978-244-1300 Fax: 978-244-1302 | |
Mr. Steven Martin Baker, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10 Industrial Ave, Chelmsford, MA 01824 Phone: 978-244-1300 |